NCT02215512View on ClinicalTrials.gov

Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain Metastases

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

February 6, 2015

Primary Completion Date

November 28, 2016

Study Completion Date

November 12, 2020

Conditions
Brain Metastases
Interventions
DRUG

RRx-001 + WBRT

Subjects will receive a combination of RRx-001 and whole brain radiotherapy.

Trial Locations (5)

48109

University of Michigan, Ann Arbor

49201

Allegiance Health, Jackson

63110

Washington University School of Medicine, St Louis

90404

Providence Saint John's Health Center, Santa Monica

08903

The Cancer Institute of New Jersey (Rutgers University), New Brunswick

Sponsors

Lead Sponsor

EpicentRx, Inc.
All Listed Sponsors
lead

EpicentRx, Inc.

INDUSTRY